A SCOTTISH pharmaceutical company behind a cancer gene therapy believed to have the potential to make chemotherapy four times more effective has secured £1.3 million of new funding.
To read the fuill story please click HERE.
A SCOTTISH pharmaceutical company behind a cancer gene therapy believed to have the potential to make chemotherapy four times more effective has secured £1.3 million of new funding.
To read the fuill story please click HERE.
[gravityform id=”2″ title=”false” ajax=”true”]
